-Reuters
Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The One Month Ended May 2023, And Year-To-Date May 2023, Based On Currently Available Information; May 23 Net Sales $4.2M-$5.1M
Scilex Holding Company (NASDAQ:SCLX, ", Scilex", )))), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (OTC:SRNEQ), an innovative revenue-generating company focused on acquiring, developing and